Follow us on LinkedIn for updates:
Day 4 focuses on the digital transformation of the life sciences, with sessions exploring the impact of AI, data economies, and precision medicine on drug discovery, clinical research, and biotech innovation. The day includes high-level keynotes, investor and legal roundtables, and parallel pitching sessions showcasing emerging startups. From AI-powered breakthroughs to regulatory and capital strategies, the agenda brings together experts from academia, industry, and policy to chart the future of digitally driven life sciences.
Chair George Pavlopoulos, Co-founder BioInnovation Greece, Greece
Speakers
Angela Spatharou, Senior Partner and Leader, EMEA Healthcare & Life Sciences, IBM Consulting , UK
Title: AI, Innovation and Health System Productivity: Delivering Value at Enterprise Level
Dimitrios Skaltsas, Co-founder & CEO, Intelligencia AI, USA
Title: Building a company- a modern Odyssey
Orestis Trasanidis, Managing Director EIT Digital, Hub Silicon Valley, Belgium
Title: Europe, It's Not the Tech. It's the Thinking
Ioannis Emiris, President and General Director, "Athena" Research and Innovation Center, Greece
Title: Is AI fulfilling its promise towards the Greek Biotech and Bioeconomy ecosystem?
Chair Michalis Aivaliotis, Associate Professor, School of Medicine, Aristotle University of Thessaloniki, Greece
Co-Chair Panagiotis Michailidis, Infectious Diseases MSc Student, DUTh, and Co-Founder & Coordinator, Panhellenic Student Conference of Bioscientists, Greece
Speakers
TBD x6
Chair TBD
Panelists
Labrina Barmpetaki, Managing Director at AbbVie, President at PhARMA Innovation Forum Greece (PIF), Greece
Vassia Tegoulia, Vice President - Head of Analytical Sciences at BioMarin Pharmaceutical Inc. USA
TBD
TBD
Kostas Syrigos, Professor of Medicine and Medical Oncology, University of Athens, School of Medicine, Greece
Olympios Papadimitriou, General Manager at Novo Nordisk & President of Hellenic Association of Pharmaceutical Companies, Greece
Joao Breda, Head, WHO Athens Quality of Care and Patient Safety Office, WHO Regional Office for Europe, Greece
TBD
Title: TBD
Chair Dora Varvarigou, Professor, School of Electrical and Computer Engineering, National Technical University of Athens (NTUA), Greece
Andreas Stavropoulos, Partner, Threshold Venture, USA
Danai Spentzou, Coordinator, Young Voices in Health Policy (YVHP), European Parliament, Belgium
TBD
TBD
Moderator Athanassios Ellis, Editor In Chief at Kathimerini English Edition, Greece
Featured Guest TBD
Chair Georgia Kokaraki, Icahn School of Medicine at Mount Sinai, USA & Co-founder & Partner, BioInnovation Greece, Greece
Rhonda Shrader, Executive Director, Berkeley Haas Entrepreneurship, USA
Nicolas Huber, Director, Commercial Operations and Partnerships, LIHE, King's College London, UK
Mike Romanos, Associate Dean for Enterprise, Faculty of Medicine, Imperial College, UK
Chair Ioanna Michalopoulou, Managing Partner Michalopoulou & Associates-Lawgroup, & Associate Partner, BioInnovation Greece
Effy Vayena, Professor at ETH Zurich, Associate Vice President for Digital Transformation & Governance, Switzerland
Georgios Papadopoulos, Investor, Founder of Atypon, USA
Lampros Kourtis, Partner, Olivetree Venture Capital, Greece
Christos Tryfonas, Technology Executive, Serial Entrepreneur, Advisor, CTO, USA
Nicholas Papandreou, Member of European Parliament, Belgium
Chair TBD